OphtalmologySynbio experts develop cells that hearETH Zurich researchers have developed a gene switch that triggers insulin release in designer cells by playing music. more ➔
CollaborationOxford Biomedica expands agreement with Ca... British CDMO Oxford Biomedica plc announces the expansion of its License and Supply Agreement with cell therapy specialist Cabaletta Bio, Inc. The new agreements adds CD19 as a new target – it originally … more ➔
MicrobiologyResearchers decipher mystery of oil-eating...Oil-eating bacteria form dendritic biofilms that reshape oil droplets to speed up the rate of consumption more ➔
financingValneva announces extension of existing lo...French vaccine maker Valneva SE will double the amount of a US$100m debt financing granted by Deerfield Management Company and OrbiMed. more ➔
financingSpexis AG bags money for pivotal Phase III...Swiss Spexis AG has announced a US$2.5m capital commitment to fund a two-part pivotal Phase III study to get market approval for its inhaled cystic fibrosis antibiotic colistimethate sodium. more ➔
M&ANovo Nordisk takes over Inversago Pharma I...With a US$1bn acquisition of Canadian Inversago Pharma, Novo Nordisk A/S fiights to maintain its dominant position in the booming weight loss drug market. more ➔
CGTPromising viral gene therapy for genetic k...British researchers have proven that a new gene can prevent progression of hereditary kidney damage in mice. more ➔
DealAlianza Team invests in microbial oil make...Lipid, nutrition and frozen bakery specialist Allianza Team puts £900,500 into pre-Series A financing of microbial palm oil producer Clean Food Group Ltd. more ➔
studyMore marine plastics than expectedA Dutch-German team of researchers has found out that the amount of not degradable plastics is lower than estimated but that they persist for longer than previously assumed. more ➔
CRo=Sygnature Discovery Ltd acquires leading C... British drug discovery specialist Sygnature Discovery Ltd has taken over Canadian NuChem Sciences Inc., one of North Americas largest discovery CROs more ➔
